Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
19 08 2020
Historique:
received: 06 07 2020
revised: 11 08 2020
accepted: 15 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 7 9 2021
Statut: epublish

Résumé

Rheumatoid arthritis (RA) is a systemic disease that leads to joint destruction. During the last decade, the therapy of RA has been principally based on biological drugs. Although the efficacy of biological therapy has been established, patients demonstrated a high heterogeneity in clinical response to treatment. Several genetic polymorphisms play a part in the different response to biological drugs. This review summarizes the pharmacogenetics of biological agents approved for clinical RA treatment. We reviewed PubMed papers published over the past 20 years (2000-2020), inserting as the search term "rheumatoid arthritis and polymorphisms". Despite some studies showing important correlations between genetic polymorphisms and response to biological therapy in RA patients, most of these findings are still lacking and inconsistent. The personalized treatment according to a pharmacogenetics approach is promising but the available pharmacogenetics data on biological treatment in RA are not adequate and reliable to recommend pharmacogenetic tests before starting biological therapy in RA patients.

Identifiants

pubmed: 32825059
pii: biom10091203
doi: 10.3390/biom10091203
pmc: PMC7565539
pii:
doi:

Substances chimiques

Biological Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Int Immunopharmacol. 2015 Sep;28(1):146-53
pubmed: 26071216
Ann Rheum Dis. 2010 Jun;69(6):1022-8
pubmed: 19966089
Hum Mol Genet. 2008 Nov 15;17(22):3532-8
pubmed: 18713756
Atherosclerosis. 2009 May;204(1):178-83
pubmed: 18848327
Autoimmun Rev. 2012 Mar;11(5):315-20
pubmed: 20974296
Rheumatol Int. 2008 Jul;28(9):901-8
pubmed: 18309487
Med J Aust. 2006 Nov 6;185(9):501-6
pubmed: 17137455
J Med Biochem. 2015 Oct;34(4):414-421
pubmed: 28356850
Pharmacogenomics J. 2009 Jun;9(3):161-7
pubmed: 19365401
Ann Rheum Dis. 2012 Jun;71(6):875-7
pubmed: 22368231
Pharmacogenet Genomics. 2014 Jan;24(1):1-5
pubmed: 24253594
Rheumatology (Oxford). 2007 Jan;46(1):93-6
pubmed: 16720636
Rheumatol Int. 2014 Oct;34(10):1409-15
pubmed: 24728031
Ann Rheum Dis. 2005 May;64(5):793-4
pubmed: 15834068
Mod Rheumatol. 2013 May;23(3):489-95
pubmed: 22760475
Clin Exp Rheumatol. 2004 Jan-Feb;22(1):118-24
pubmed: 15005015
Arthritis Rheum. 2007 Dec 15;57(8):1426-30
pubmed: 18050183
Pharmacogenet Genomics. 2014 Aug;24(8):401-5
pubmed: 24978393
Rheumatol Int. 2006 Dec;27(2):157-61
pubmed: 16909270
Scand J Rheumatol. 2006 Nov-Dec;35(6):435-40
pubmed: 17343250
Joint Bone Spine. 2012 Dec;79(6):591-6
pubmed: 22480748
Eur Cytokine Netw. 2011 Dec;22(4):175-80
pubmed: 22285486
Genes Immun. 2000 Oct;1(7):428-34
pubmed: 11196673
Arthritis Rheum. 2003 Jul;48(7):1849-52
pubmed: 12847678
Arthritis Rheum. 2013 Jan;65(1):88-97
pubmed: 23001900
Rheumatology (Oxford). 2007 Jun;46(6):1034-5
pubmed: 17409133
Nat Clin Pract Rheumatol. 2006 Dec;2(12):654-60
pubmed: 17133250
Reumatismo. 2010 Oct-Dec;62(4):253-8
pubmed: 21253618
Semin Arthritis Rheum. 2015 Aug;45(1):35-41
pubmed: 25837015
Ann Rheum Dis. 2014 Apr;73(4):716-21
pubmed: 23505228
J Clin Pharmacol. 2019 Apr;59(4):517-531
pubmed: 30457672
Joint Bone Spine. 2012 Oct;79(5):471-5
pubmed: 22129793
Rheumatology (Oxford). 2005 Apr;44(4):547-52
pubmed: 15695296
Rheumatol Int. 2013 Jun;33(6):1481-6
pubmed: 23233117
Pharmacogenet Genomics. 2015 Jul;25(7):323-33
pubmed: 25850964
Lancet. 2010 Sep 25;376(9746):1094-108
pubmed: 20870100
Pharmacogenomics J. 2018 Jan;18(1):167-172
pubmed: 27958380
Arthritis Rheum. 2002 Dec;46(12):3143-50
pubmed: 12483717
RMD Open. 2017 Nov 1;3(2):e000485
pubmed: 29177079
Arthritis Res Ther. 2011 Jul 08;13(4):R111
pubmed: 21740541
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1217-22
pubmed: 20203245
Ann Intern Med. 2008 Jan 15;148(2):124-34
pubmed: 18025440
Joint Bone Spine. 2015 Mar;82(2):94-9
pubmed: 25311255
BMJ Open. 2012 Sep 22;2(5):
pubmed: 23002160
Rheumatology (Oxford). 2013 Apr;52(4):636-41
pubmed: 23264555
Semin Hematol. 2010 Apr;47(2):115-23
pubmed: 20350658
J Invest Dermatol. 2014 Oct;134(10):2503-2509
pubmed: 24594669
Rheumatol Ther. 2017 Dec;4(2):247-261
pubmed: 28831712
Ann Rheum Dis. 2008 Apr;67(4):478-84
pubmed: 17673491
Best Pract Res Clin Rheumatol. 2007 Oct;21(5):943-67
pubmed: 17870037
Pharmacogenomics J. 2019 Aug;19(4):368-374
pubmed: 30647443
Rheumatol Int. 2017 Sep;37(9):1551-1557
pubmed: 28455559
Genes Immun. 2005 Sep;6(6):467-71
pubmed: 15931231
Clin Exp Rheumatol. 2013 Sep-Oct;31(5):813
pubmed: 23739065

Auteurs

Giovanni Pallio (G)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Federica Mannino (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Natasha Irrera (N)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Ali H Eid (AH)

Department of Pharmacology and Toxicology, American University of Beirut, Bliss Street, Riad El Solh, 1107-2020 Beirut, Lebanon.

Francesco Squadrito (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Alessandra Bitto (A)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH